Cargando…
筛状成分在肺腺癌中的研究进展
The morbidity of lung cancer ranks top in the world. At present, lung adenocarcinoma (LUAD) is the most common histologic type of lung cancer. However, the prognoses of LUAD patients with the same subtype remain heterogeneous. Histological heterogeneity is one of the main causes of diverse prognoses...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406433/ https://www.ncbi.nlm.nih.gov/pubmed/32450628 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.101.19 |
_version_ | 1783567418907426816 |
---|---|
collection | PubMed |
description | The morbidity of lung cancer ranks top in the world. At present, lung adenocarcinoma (LUAD) is the most common histologic type of lung cancer. However, the prognoses of LUAD patients with the same subtype remain heterogeneous. Histological heterogeneity is one of the main causes of diverse prognoses of patients with LUAD. Studies have shown that there are other histologic patterns that affect the clinical outcomes of LUAD patients, in addition to the five growth patterns of invasive LUAD classified by the World Health Organization (WHO) in 2015. The cribriform component (CC) is one of the research hotspots among histopathology of LUAD. Previous studies have shown that the presence of CC can further stratify the prognoses of patients with LUAD. Along with the progressively deep insights into the aforementioned topic, researchers are dedicating to unveiling the relationships among CC and and other clinicopathological factors as well as their joint influence on the survival of LUAD patients. The review manages to generalize the latest research progress in the CC in LUAD patients. |
format | Online Article Text |
id | pubmed-7406433 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | 中国肺癌杂志编辑部 |
record_format | MEDLINE/PubMed |
spelling | pubmed-74064332020-08-13 筛状成分在肺腺癌中的研究进展 Zhongguo Fei Ai Za Zhi 综述 The morbidity of lung cancer ranks top in the world. At present, lung adenocarcinoma (LUAD) is the most common histologic type of lung cancer. However, the prognoses of LUAD patients with the same subtype remain heterogeneous. Histological heterogeneity is one of the main causes of diverse prognoses of patients with LUAD. Studies have shown that there are other histologic patterns that affect the clinical outcomes of LUAD patients, in addition to the five growth patterns of invasive LUAD classified by the World Health Organization (WHO) in 2015. The cribriform component (CC) is one of the research hotspots among histopathology of LUAD. Previous studies have shown that the presence of CC can further stratify the prognoses of patients with LUAD. Along with the progressively deep insights into the aforementioned topic, researchers are dedicating to unveiling the relationships among CC and and other clinicopathological factors as well as their joint influence on the survival of LUAD patients. The review manages to generalize the latest research progress in the CC in LUAD patients. 中国肺癌杂志编辑部 2020-07-20 /pmc/articles/PMC7406433/ /pubmed/32450628 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.101.19 Text en 版权所有©《中国肺癌杂志》编辑部2020 This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/. |
spellingShingle | 综述 筛状成分在肺腺癌中的研究进展 |
title | 筛状成分在肺腺癌中的研究进展 |
title_full | 筛状成分在肺腺癌中的研究进展 |
title_fullStr | 筛状成分在肺腺癌中的研究进展 |
title_full_unstemmed | 筛状成分在肺腺癌中的研究进展 |
title_short | 筛状成分在肺腺癌中的研究进展 |
title_sort | 筛状成分在肺腺癌中的研究进展 |
topic | 综述 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406433/ https://www.ncbi.nlm.nih.gov/pubmed/32450628 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.101.19 |
work_keys_str_mv | AT shāizhuàngchéngfēnzàifèixiànáizhōngdeyánjiūjìnzhǎn AT shāizhuàngchéngfēnzàifèixiànáizhōngdeyánjiūjìnzhǎn AT shāizhuàngchéngfēnzàifèixiànáizhōngdeyánjiūjìnzhǎn AT shāizhuàngchéngfēnzàifèixiànáizhōngdeyánjiūjìnzhǎn |